Alice Zhang was a graduate student in neuroscience when she realized that the drug discovery process could be revolutionized by rapid advances in multiple fields. Then she decided that she’d be the one to revolutionize it. Today, she leads Verge Genomics, which aims to develop better drugs faster using artificial intelligence and an “all-in-human” approach.
Our signature newsletter with insights and analysis from across the firm
By submitting this information, you agree that the information you are providing is subject to Goldman Sachs’ privacy policy and Terms of Use. You consent to receive our newletter via email.